GENOME-WIDE METHYLATION PROFILING
OF SCHIZOPHRENIA
Rukova B1, Staneva R1, Hadjidekova S1, Stamenov G2, Milanova V3, Toncheva D1,
*Corresponding Author: Professor Draga Toncheva, Department of Medical Genetics, Medical University of
Sofia, 1431 2 Zdrave Str., Sofia, Bulgaria. Tel./Fax: +35929520357. Email: dragatoncheva@ gmail.com
page: 15
|
|
REFERENCES
1. Tsuang MT, Faraone SV, Glatt SJ. Schizophrenia,
3rd ed. New York, NY: Oxford University
Press, 2011.
2. Sullivan PF, Kendler KS, Neale MC. Schizophrenia
as a complex trait: evidence from a metaanalysis
of twin studies. Arch Gen Psychiatry.
2003; 60(12): 1187-1192.
3. Stilo SA, Murray RM. The epidemiology of
schizophrenia: replacing dogma with knowledge.
Dialogues Clin Neurosci. 2010; 12(3):
305-315.
4. van Os J, Kapur S. Schizophrenia. Lancet. 2009;
374(9690): 635-645.
5. Turck CW, Maccarrone G, Sayan-Ayata E, Jacob
AM, Ditzen C, Kronsbein H, et al. The quest for
brain disorder biomarkers. J Med Invest. 2005;
52(Suppl): 231-235.
6. Bird A. Perceptions of epigenetics. Nature. 2007;
447(7143): 396-398.
7. Bird AP. CpG-rich islands and the function of
DNA methylation. Nature. 1986; 321(6067):
209-213.
8. Bjornsson HT, Sigurdsson MI, Fallin MD, Irizarry
RA, Aspelund T, Cui H, et al. Intra-individual
change over time in DNA methylation with familial
clustering. JAMA. 2008; 299(24): 2877-
2883.
9. Jones PA. Functions of DNA methylation: Islands,
start sites, gene bodies and beyond. Nat
Rev Genet. 2012; 13(7): 484-492.
10. Moore LD, Le T, Fan G. DNA Methylation and
its basic function. Neuropsychopharmacology.
2013; 38(1): 23-38.
11. Rakyan VK, Down TA, Thorne NP, Flicek P,
Kulesha E, Graf S, et al. An integrated resource
for genome-wide identification and analysis of
human tissue-specific differentially methylated
regions (tDMRs). Genome Res. 2008; 18(9):
1518-1529.
12. Connor CM, Akbarian S. DNA methylation
changes in schizophrenia and bipolar disorder.
Epigenetics. 2008; 3(2): 55-58.
13. Betcheva ET, Mushiroda T, Takahashi A, Kubo
M, Karachanak SK, Zaharieva IT, et al. Casecontrol
association study of 59 candidate genes
reveals the DRD2 SNP rs6277 (C957T) as the
only susceptibility factor for schizophrenia in
the Bulgarian population. J Hum Genet. 2009;
54(2): 98-107.
14. Consortium TIS. Common polygenic variation
contributes to risk of schizophrenia and bipolar
disorder. Nature. 2009; 460(7256): 748-752.
15. Kirov G, Pocklington AJ, Holmans P, Ivanov D,
Ikeda M, Ruderfer D, et al. De novo CNV analysis
implicates specific abnormalities of postsynaptic
signalling complexes in the pathogenesis
of schizophrenia. Mol Psychiatry. 2012; 17(2):
142-153.
16. Raychaudhuri S, Korn JM, McCarroll SA, Altshuler
D, Sklar P, Purcell S, et al. Accurately
assessing the risk of schizophrenia conferred
by rare copy-number variation affecting genes
with brain function. PLoS Genet. 2010; 6(9):
e1001097.
17. Zaharieva I, Georgieva L, Nikolov I, Kirov G,
Owen MJ, O’Donovan MC, et al. Association
study in the 5q31-32 linkage region for schizophrenia
using pooled DNA genotyping. BMC
Psychiatry. 2008; 8: 11.
18. Weber M, Davies JJ, Wittig D, Oakeley EJ,
Haase M, Lam WL, et al. Chromosome-wide
and promoter-specific analyses identify sites
of differential DNA methylation in normal and
transformed human cells. Nat Genet. 2005;
37(8): 853-862.
19. Jia J, Pekowska A, Jaeger S, Benoukraf T, Ferrier
P, Spicuglia S. Assessing the efficiency and significance
of Methylated DNA Immunoprecipitation
(MeDIP) assays in using in vitro methylated
genomic DNA. BMC Res Notes. 2010; 3: 240.
20. Down TA, Rakyan VK, Turner DJ, Flicek P, Li
H, Kulesha E, et al. A Bayesian deconvolution
strategy for immunoprecipitation-based DNA
methylome analysis. Nat Biotechnol. 2008;
26(7): 779-785.
21. Liekens AM, De Knijf J, Daelemans W, Goethals
B, De Rijk P, Del-Favero J. BioGraph: unsupervised
biomedical knowledge discovery via
automated hypothesis generation. Genome Biol.
2011; 12(6): R57.
22. Watanabe M, Kanbara K. GABA and GABA
Receptors in the Central Nervous System and
Other Organs, vol. 213. San Diego, CA: Academic
Press, 2002.
23. Liu J, Morgan M, Hutchison K, Calhoun VD. A
study of the influence of sex on genome wide
methylation. PLoS One. 2010; 5(4): e10028.
24. Canuso CM, Pandina G. Gender and schizophrenia.
Psychopharmacol Bull. 2007; 40(4):
178-190.
25. Bullock WM, Cardon K, Bustillo J, Roberts
RC, Perrone-Bizzozero NI. Altered expression
of genes involved in GABAergic transmission
and neuromodulation of granule cell activity in
the cerebellum of schizophrenia patients. Am J
Psychiatry. 2008; 165(12): 1594-1603.
26. Nishioka M, Bundo M, Koike S, Takizawa R,
Kakiuchi C, Araki T, et al. Comprehensive DNA
methylation analysis of peripheral blood cells
derived from patients with first-episode schizophrenia.
J Hum Genet. 2013; 58(2): 91-97.
27. Dempster EL, Pidsley R, Schalkwyk LC, Owens
S, Georgiades A, Kane F, et al. Disease-associated
epigenetic changes in monozygotic twins
discordant for schizophrenia and bipolar disorder.
Hum Molec Genet. 2011; 20(24): 4786-4796.
28. Nakai T, Kitamura N, Hashimoto T, Kajimoto Y,
Nishino N, Mita T, et al. Decreased histamine
H1 receptors in the frontal cortex of brains from
patients with chronic schizophrenia. Biol Psychiatry.
1991; 30(4): 349-356.
29. Lee ST, Ryu S, Kim SR, Kim MJ, Kim S, Kim
JW, et al. Association study of 27 annotated
genes for clozapine pharmacogenetics: validation
of preexisting studies and identification of
a new candidate gene, ABCB1, for treatment
response. J Clin Psychopharmacol. 2012; 32(4):
441-448.
30. Vehof J, Risselada AJ, Al Hadithy AF, Burger
H, Snieder H, Wilffert B, et al. Association of
genetic variants of the histamine H1 and muscarinic
M3 receptors with BMI and HbA1c values
in patients on antipsychotic medication. Psychopharmacology
(Berlin). 2011; 216(2): 257-265.
31. Gaughran F, Payne J, Sedgwick PM, Cotter
D, Berry M. Hippocampal FGF-2 and FGFR1
mRNA expression in major depression, schizophrenia
and bipolar disorder. Brain Res Bull.
2006; 70(3): 221-227.
32. Bader V, Tomppo L, Trossbach SV, Bradshaw
NJ, Prikulis I, Leliveld SR, et al. Proteomic,
genomic and translational approaches identify
CRMP1 for a role in schizophrenia and its underlying
traits. Hum Mol Genet. 2012; 21(20):
4406-4418.
33. Bornhauser BC, Olsson PA, Lindholm D. MSAP
is a novel MIR-interacting protein that enhances
neurite outgrowth and increases myosin regulatory
light chain. J Biol Chem. 2003; 278(37):
35412-35420.
34. Hamajima N, Matsuda K, Sakata S, Tamaki N,
Sasaki M, Nonaka M. A novel gene family defined
by human dihydropyrimidinase and three
related proteins with differential tissue distribution.
Gene. 1996; 180(1-2): 157-163.
35. Olsson PA, Korhonen L, Mercer EA, Lindholm
D. MIR is a novel ERM-like protein that interacts
with myosin regulatory light chain and
inhibits neurite outgrowth. J Biol Chem. 1999;
274(51): 36288-36292.
36. Soundararajan P, Fawcett JP, Rafuse VF. Guidance
of postural motoneurons requires MAPK/ERK
signaling downstream of fibroblast growth factor
receptor 1. J Neurosci. 2010; 30(19): 6595-6606.
37. Yamashita N, Uchida Y, Ohshima T, Hirai S, Nakamura
F, Taniguchi M, et al. Collapsin response
mediator protein 1 mediates reelin signaling in
cortical neuronal migration. J Neurosci. 2006;
26(51): 13357-13362.
38. Jarskog LF, Glantz LA, Gilmore JH, Lieberman
JA. Apoptotic mechanisms in the pathophysiology
of schizophrenia. Prog Neuropsychopharmacol
Biol Psychiatry. 2005; 29(5): 846-858.
39. Kerns D, Vong GS, Barley K, Dracheva S, Katsel
P, Casaccia P, et al. Gene expression abnormalities
and oligodendrocyte deficits in the internal
capsule in schizophrenia. Schizophr Res. 2010;
120(1-3): 150-158.
40. Catts VS, Catts SV, McGrath JJ, Féron F, McLean
D, Coulson EJ, et al. Apoptosis and schizophrenia:
A pilot study based on dermal fibroblast cell
lines. Schizophr Res. 2006; 84(1): 20-28.
41. Boston-Howes W, Gibb SL, Williams EO, Pasinelli
P, Brown RH, Trotti D. Caspase-3 cleaves
and inactivates the glutamate transporter EAAT2.
J Biol Chem. 2006; 281(20): 14076-14084.
42. Sari Y, Zhou FC. Prenatal alcohol exposure
causes long-term serotonin neuron deficit in
mice. Alcohol Clin Exp Res. 2004; 28(6): 941-
948.
43. Riedl SJ, Renatus M, Schwarzenbacher R, Zhou
Q, Sun C, Fesik SW, et al. Structural basis for
the inhibition of Caspase-3 by XIAP. Cell. 2001;
104(5): 791-800.
44. Meynen G, Unmehopa UA, Hofman MA, Swaab
DF, Hoogendijk WJ. Hypothalamic oxytocin
mRNA expression and melancholic depression.
Mol Psychiatry. 2007; 12(2): 118-119.
45. Kyosseva SV. The role of the extracellular signal-
regulated kinase pathway in cerebellar abnormalities
in schizophrenia. Cerebellum. 2004;
3(2): 94-99.
46. Lin DC, Quevedo C, Brewer NE, Bell A, Testa
JR, Grimes ML, et al. APPL1 Associates with
TrkA and GIPC1 and is required for nerve
growth factor-mediated signal transduction. Mol
Cell Biol. 2006; 26(23): 8928-8941.
47. Yano H, Ninan I, Zhang H, Milner TA, Arancio
O, Chao MV. BDNF-Mediated neurotransmission
relies upon a myosin VI motor complex.
Nat Neurosci. 2006; 9(8): 1009-1018.
|
|
|
|
 |
Number 26
VOL. 26(1), 2023 |
Number 25
VOL. 25(2), 2022 |
Number 25
VOL. 25 (1), 2022 |
Number 24
VOL. 24(2), 2021 |
Number 24
VOL. 24(1), 2021 |
Number 23
VOL. 23(2), 2020 |
Number 22
VOL. 22(2), 2019 |
Number 22
VOL. 22(1), 2019 |
Number 22
VOL. 22, 2019 Supplement |
Number 21
VOL. 21(2), 2018 |
Number 21
VOL. 21 (1), 2018 |
Number 21
VOL. 21, 2018 Supplement |
Number 20
VOL. 20 (2), 2017 |
Number 20
VOL. 20 (1), 2017 |
Number 19
VOL. 19 (2), 2016 |
Number 19
VOL. 19 (1), 2016 |
Number 18
VOL. 18 (2), 2015 |
Number 18
VOL. 18 (1), 2015 |
Number 17
VOL. 17 (2), 2014 |
Number 17
VOL. 17 (1), 2014 |
Number 16
VOL. 16 (2), 2013 |
Number 16
VOL. 16 (1), 2013 |
Number 15
VOL. 15 (2), 2012 |
Number 15
VOL. 15, 2012 Supplement |
Number 15
Vol. 15 (1), 2012 |
Number 14
14 - Vol. 14 (2), 2011 |
Number 14
The 9th Balkan Congress of Medical Genetics |
Number 14
14 - Vol. 14 (1), 2011 |
Number 13
Vol. 13 (2), 2010 |
Number 13
Vol.13 (1), 2010 |
Number 12
Vol.12 (2), 2009 |
Number 12
Vol.12 (1), 2009 |
Number 11
Vol.11 (2),2008 |
Number 11
Vol.11 (1),2008 |
Number 10
Vol.10 (2), 2007 |
Number 10
10 (1),2007 |
Number 9
1&2, 2006 |
Number 9
3&4, 2006 |
Number 8
1&2, 2005 |
Number 8
3&4, 2004 |
Number 7
1&2, 2004 |
Number 6
3&4, 2003 |
Number 6
1&2, 2003 |
Number 5
3&4, 2002 |
Number 5
1&2, 2002 |
Number 4
Vol.3 (4), 2000 |
Number 4
Vol.2 (4), 1999 |
Number 4
Vol.1 (4), 1998 |
Number 4
3&4, 2001 |
Number 4
1&2, 2001 |
Number 3
Vol.3 (3), 2000 |
Number 3
Vol.2 (3), 1999 |
Number 3
Vol.1 (3), 1998 |
Number 2
Vol.3(2), 2000 |
Number 2
Vol.1 (2), 1998 |
Number 2
Vol.2 (2), 1999 |
Number 1
Vol.3 (1), 2000 |
Number 1
Vol.2 (1), 1999 |
Number 1
Vol.1 (1), 1998 |
|
|
|
